Attached files
| file | filename |
|---|---|
| EX-5.1 - EX-5.1 - NeuroPace Inc | exhibit51-sx1mef.htm |
| S-1MEF - S-1MEF - NeuroPace Inc | neuropaceinc-sx1mef.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-1 of our report dated March 24, 2021, except for the effects of the reverse stock split discussed in Note 2 to the financial statements, as to which the date is April 14, 2021, relating to the financial statements, which appears in Post-Effective Amendment No. 1 to the Registration Statement on Form S-1 (No. 333-254663) of NeuroPace, Inc. We also consent to the reference to us under the heading “Experts” in Post-Effective Amendment No. 1 to the Registration Statement on Form S-1 (No. 333-254663) incorporated by reference in this Registration Statement.
/s/ PricewaterhouseCoopers LLP
San Jose, California
April 21, 2021